Key upcoming milestones include expert discovery completion, scheduled for March 27, 2026
Int J Clin Pharmacol Res 1990;10:355-60
Strategies for GSH system activation Identifying strategies that fortify the GSH system in the heart may contribute to developing therapies against cardiac diseases induced by various pathological factors
In 2017, semaglutide received FDA approval for treatment of diabetes at a dose of 1 mg
Unlike self-directed weight loss methods, these programs provide precise dosing, ongoing monitoring, and personalized adjustments to maximize effectiveness while minimizing potential risks
Peer review Peer review information Nature Chemistry thanks Daniel Reker and the other, anonymous, reviewer(s) for their contribution to the peer review of this work